collaborative clinical medicines procurement (ccmp) “ getting value for money ”
DESCRIPTION
Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”. Colette Whigham Category Manager – Pharmacy NHS National Procurement, Scotland Thursday 11 th November 2010. National Procurement. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/1.jpg)
Collaborative Clinical Medicines Procurement Collaborative Clinical Medicines Procurement (CCMP) (CCMP)
“Getting Value for Money”“Getting Value for Money”Colette Whigham
Category Manager – PharmacyNHS National Procurement, Scotland
Thursday 11th November 2010
![Page 2: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/2.jpg)
National Procurement
Commenced activities in Scotland in 2005 following recommendations made by the McClelland review of public sector procurement.
Purchasing activities across the NHSS historically had been managed:-
– In a sporadic manner
– Limited coordination across NHS Scotland
– Little aggregation of spend across NHS Scotland and more than 23
procurement organisations
![Page 3: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/3.jpg)
Workstream Activity Redesign
Logistics
Strategic Sourcing
Maximise the potential savings by NHS Scotland by sharing the benefits of collaborative buying power. These are
realised by the application of best practice strategic sourcing processes and working with suppliers to obtain best value
products and services.
eP&S
Coordinate the deployment of world class procurement technology across Health Boards. This offers users access
to a variety of tools that support strategic and transactional procurement and enable new methods of
collaboration.
Simplify the physical supply chain using managed distribution systems to achieve economies of scale delivered
from the National Distribution Centre. (Non Pharmaceuticals)
![Page 4: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/4.jpg)
Scottish Pharmacologistics Governance Framework
CLINICAL
INPUT
PROCUEMENT
PharmacologisticsStrategy Group (PSG)
Scottish GovernmentHealth Directorate
Directors of Pharmacy
NP Director PASAG Secratariat
Scottish PharmacyBusiness Technology
Group (SPBTG)
Patient Access Scheme Administration Group
(PASAG)
Emergency PlanningGroup
Homecare Group
PharmacologisticsOperational Group (POG)
VaccinesOperational Group (VOG)
Scottish Pharmacy Market Strategy Group(SPMSG)
Transitional Products Group
East Zone West Zone North Zone
![Page 5: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/5.jpg)
National Contracting Strategy for Medicines
Key Elements:-
– Procurement Regulations– Clinical Involvement– Specification Design– Contract Shape– Supplier Conditioning– Anticipated Outcomes– Implementation
![Page 6: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/6.jpg)
National Contracting Strategy for Medicines
Key Features:-– Clear– Transparent– Planned– Efficient– Joined Up– Delivers Savings Consistently– Clinical Governance– Financial Governance
![Page 7: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/7.jpg)
National Contracting Challenges
• Resistance to and fear of change• Lack of awareness of procurement regulations• Lack of understanding of market dynamics• Industry Resistance• Lack of clinical resource to implement change
It’s too ambitious
No one asked
me
It will take to long!
It’s tooexpensive
I don’t have authority
It’s impossible
We can’t take the chance
It’s toocomplicated
They won’t fund it
What’s in it for me?
We’ve always done it this way!It’s too
politicalWe are
doing ok as it is!!
We don’t have the
staff
It’s not my job!!
We tried that before
I’m all for it, but…
They really don’t want to
change
We’ve never done that
beforeThere’s not
enough time It needs more
thought
It’s not our problem!!
It won’t work in this department
![Page 8: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/8.jpg)
Clinical Peer Groups in Scotland actively engaged with National Procurement
• Diabetes Action Plan – Scottish Government• Hepatitis C Action Plan – Scottish Government• Scottish HIV Action Group - Scottish Government• Scottish Antimicrobial Pharmacy Group• Scottish Radiological Society• Scottish Society for Rheumatology• Scottish Plasma Expert Panel• Scottish Haemophilia Directors• Scottish Cancer Networks• Scottish Fertility Group• Total Parenteral Nutrition Managed Clinical Network• Scottish Neonatal and Paediatric Pharmacists• Scottish Critical Care Pharmacy Group• Scottish Pharmacists Quality Assurance Group • Patient Access Scheme Advisory Group (PASAG)
![Page 9: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/9.jpg)
Lessons Learned
• Communication (Stakeholders and Industry)• Planning• Change for sake of change• Well developed specifications• Anticipate outcomes• Shared resource (Reduced representation at
Clinical Level but endorsed nationally via peer groups)
![Page 10: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/10.jpg)
Thankfully there are not too many of these !!
![Page 11: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/11.jpg)
Examples of Successful Collaborative Clinical Medicines Procurement in Scotland
• Low Molecular Weight Heparin – Product Standardisation• Hepatitis C Action Plan – Volume Matrix• Botulinum Toxin Type A – Clinical Substitution without rationalisation• IVF Fertility – Price Normalisation• Insulin Pumps – Ranked Framework• Clozapine – Single Supplier Framework• Homecare – Single Supplier Framework, HIV & Clotting Factors• Blood Glucose Monitoring Strips – Supplier Rationalisation• Contrast Media – Supplier Rationalisation, release market share• G-CSF – Scotland Wide Clinical Input• Gonadorelin Analogues - Clinical Substitution without rationalisation• Total Parenteral Nutrition• Erythropoetin Stimulating Agents• Transitional Medicines – Time to market, when is the right time?
![Page 12: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/12.jpg)
We do not always get it right first time!!
![Page 13: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/13.jpg)
Collaborative Clinical Medicines Procurement “Getting Value for Money”
The Results:
– 2005/2006 = £4,721,238– 2006/2007 = £8,953,191– 2007/2008 = £5,873,646– 2008/2009 = £5,128,995– 2009/2010 = £5,713,346
Total Savings To Date = £ 30,390,416
![Page 14: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/14.jpg)
The Future…
• More complex therapy areas (Work In Progress):– Continued Therapeutic Substitution– Anti-fungals– Anti-TNF’s– Anti-thrombolytics
• Closer collaborative working with Scottish Medicines Consortium (SMC)
• Closer collaborative working with National/Health Board Formularies
• Continued development of focused Clinical Advisory Panels
![Page 15: Collaborative Clinical Medicines Procurement (CCMP) “ Getting Value for Money ”](https://reader030.vdocuments.net/reader030/viewer/2022033108/56814903550346895db636aa/html5/thumbnails/15.jpg)
Summary
• No two procurement procedures are the same• Clinical input at the centre of all procurement
activity• Savings are a key NHS agenda item• Change management, whilst challenging, is
always possible• Future contracts will benefit from lessons learned • Procurement and Clinical resource is essential• Make a plan and stick to it!